CAS 681282-09-7

MYCMI-6

Description:

MYCMI-6, with the CAS number 681282-09-7, is a synthetic compound that belongs to the class of small molecules. It is primarily recognized for its potential applications in medicinal chemistry, particularly in the development of therapeutic agents. The compound exhibits specific structural features that contribute to its biological activity, including a unique arrangement of functional groups that may interact with biological targets. MYCMI-6 has been studied for its role in inhibiting certain cellular pathways, which can be relevant in cancer research and other disease models. Its solubility, stability, and reactivity are important characteristics that influence its efficacy and bioavailability in biological systems. As with many synthetic compounds, understanding its pharmacokinetics and pharmacodynamics is crucial for evaluating its therapeutic potential. Ongoing research may further elucidate its mechanisms of action and broaden its applications in various fields of biomedical research.

Formula: C₂₀H₁₉N₇O

Synonyms:

• 2,6-Pyridinediamine, 3-[2-(9-amino-7-ethoxy-3-acridinyl)diazenyl]-
• NSC354961
• MYCMI-6
• MYCMI-6(NSC 354961)

MYCMI-6

CAS: 681282-09-7

MYCMI-6 inhibits MYC:MAX, reduces tumor growth, triggers apoptosis, minimal side effects.

Formula: C₂₀H₁₉N₇O

Purity: 99.23%

Color and Shape: Solid

Molecular weight: 373.41

Ref: TM-T12134

3-((9-Amino-7-ethoxyacridin-3-yl)diazenyl)pyridine-2,6-diamine

CAS: 681282-09-7

Formula: C₂₀H₁₉N₇O

Purity: 98%

Color and Shape: Solid

Molecular weight: 373.4112

Ref: IN-DA01NI89

3-((9-Amino-7-Ethoxyacridin-3-Yl)Diazenyl)Pyridine-2,6-Diamine

CAS: 681282-09-7

3-((9-Amino-7-Ethoxyacridin-3-Yl)Diazenyl)Pyridine-2,6-Diamine

Purity: 98%

Molecular weight: 373.41g/mol

Ref: 54-OR1022854

MYCMI-6

CAS: 681282-09-7

MYCMI-6

Purity: ≥95%

Molecular weight: 373.41g/mol

Ref: 54-BUP08733

MYCMI-6

CAS: 681282-09-7

MYCMI-6 is a small molecule that interacts with telomerase and inhibits the enzyme's activity. MYCMI-6 has been shown to inhibit tumor growth in vitro assays and in vivo mouse models. It also stabilizes proteins and acts as a cancer drug target. The efficacy of this drug has been demonstrated for solid tumours, such as colorectal carcinoma, breast cancer, and prostate cancer. MYCMI-6 has also shown promise for treating other cancers including lung cancer, leukemia, melanoma, and pancreatic cancer.

Formula: C₂₀H₁₉N₇O

Purity: Min. 95%

Molecular weight: 373.41 g/mol

Ref: 3D-FM170338

3-((9-Amino-7-ethoxyacridin-3-yl)diazenyl)pyridine-2,6-diamine

CAS: 681282-09-7

Formula: C₂₀H₁₉N₇O

Purity: 98%

Molecular weight: 373.42

Ref: 10-F547714